Download PDF
1 / Pages

Other users also viewed these articles

Prevalence and risk factors of significant fibrosis in chronic hepatitis B patients with concurrent metabolic dysfunction-associated steatotic liver disease Shan Hong; Yiwei Hao; Lei Sun; Ping Li; Junru Yang; Fuyang Zhang; Lingling He; Jing Zhang; Hongshan Wei;
10.1016/j.aohep.2024.101589
P-35 CLINICAL AND EPIDEMIOLOGICAL DIFFERENCES BETWEEN PATIENTS MONOINFECTED WITH HEPATITIS B AND COINFECTED WITH HEPATITIS DELTA IN A HYPERENDEMIC REGION OF HEPATITIS B Walter Silva Junior Junior; Jadson Dourado Costa; Ingrid Laise Vivas; Sidelcina Rugieri Pacheco; Ezequiel Ridruejo; Juan Salcedo; Deusilene Souza Dallacqua; Raymundo Paraná; Maria Izabel Schinoni;
Ann Hepatol. 2024;29 Supl 3:
OP- 10 - NON-STEROIDAL ANTI-INFLAMMATORY DRUGS: A COMPARATIVE ANALYSIS BETWEEN THE SPANISH AND LATINDILI NETWORKS FERNANDO BESSONE; Ismael Alvarez Alvarez; Nelia Hernandez; Maria Isabel Schinoni; Inmaculada Medina Caliz; Hugo Tanno; Hao Niu; Maria Virginia Reggiardo; Federico Tanno; Gabriel Rifrani; Ezequiel Ridruejo; Manuel Mendizabal; Raymundo Paraná; Eduardo Luis Fassio; Daiana Arnedillo; Antonella Cordone; Daniela Chiodi; Gisela Gualano; Javier Brahm; Maria Isabel Lucena Gonzalez; Raúl Jesus Andrade;
Ann Hepatol. 2024;29 Supl 3: